Real-World Effectiveness of Palbociclib Versus Clinical Trial Results in Patients With Advanced/Metastatic Breast Cancer That Progressed on Previous Endocrine Therapy

OBJECTIVE: The aim of this study was to assess the real-world effectiveness and tolerability of palbociclib combined with endocrine therapy for the treatment of hormone receptor positive (HR-positive), human epidermal growth factor receptor 2 negative (HER2-negative), advanced/metastatic breast canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Bui, Tam Binh V, Burgers, Desirée MT, Agterof, Mariette J, van de Garde, Ewoudt MW
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330732/
https://www.ncbi.nlm.nih.gov/pubmed/30675102
http://dx.doi.org/10.1177/1178223418823238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330732/
https://www.ncbi.nlm.nih.gov/pubmed/30675102
http://dx.doi.org/10.1177/1178223418823238

Ejemplares similares